No Data
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating
We Think Lifecore Biomedical (NASDAQ:LFCR) Has A Fair Chunk Of Debt
Lifecore Biomedical's Strategic Asset Sale Supports Hold Rating Amid Leverage Concerns
Lifecore Biomedical Announces $17M Sales Agreement For 10-Head Isolator Filler, Receives $7M At Closing, Expects Remaining Payments In 3 Tranches Over 18 Months
Express News | Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million